Loading…
image

Report Scope & Overview:

Companion Animal Arthritis Market size was valued at $2.9 Billion in 2021, and is projected to reach $5.5 Billion by 2031, growing at a CAGR of 7% from 2022 to 2031.

Companion Animal Arthritis Market Overview:
Global Companion Animal Arthritis Market research provides insights into consumer behavior, industry trends, and market competition through the use of various research techniques, including surveys, interviews, and data analysis. The industry serves a wide range of clients, including businesses, government agencies, and non-profit organizations. Companion Animal Arthritis Market is highly diverse, with a range of services and specialties, including quantitative and qualitative research, brand research, product testing, customer satisfaction research, and competitive analysis.
Overall, Companion Animal Arthritis market plays a crucial role in helping businesses and organizations make informed decisions based on data-driven insights. As the demand for data-driven decision-making continues to grow, Companion Animal Arthritis market research is expected to experience further growth and innovation in the coming years.

DESCIMG1

Companion Animal Arthritis Market Key Trends

Rising Prevalence of Arthritis: Arthritis is a common condition in aging companion animals, including dogs and cats. The increasing lifespan of pets and improved diagnostic capabilities have led to a higher awareness of arthritis, contributing to its prevalence.

Early Diagnosis and Intervention: There is a growing emphasis on early diagnosis and intervention for arthritis in pets. Veterinarians are increasingly using diagnostic tools such as radiography, ultrasound, and blood tests to detect arthritis in its early stages.

Multimodal Pain Management: The trend in pain management for companion animals with arthritis involves multimodal approaches. This includes a combination of medications, physical therapy, weight management, and nutraceuticals to improve pain control and overall quality of life.

Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): NSAIDs remain a standard treatment for managing pain and inflammation in arthritic pets. Ongoing research focuses on the development of safer and more effective NSAIDs with fewer side effects.

Nutraceuticals and Supplements: The use of nutraceuticals and dietary supplements containing ingredients like glucosamine, chondroitin, omega-3 fatty acids, and antioxidants is on the rise. These supplements are believed to support joint health and reduce inflammation.

Market Segmentations:
Global Companion Animal Arthritis Market: By Company
• Zoetis
• Virbac
• Elanco
• Boehringer Ingelheim International GmbH
• Ceva
• Dechra Pharmaceuticals PLC.
• Vetoquinol
• NexGen Pharmaceuticals
• Norbrook
• Eltech K-Laser s.r.l.

Global Companion Animal Arthritis Market: By Type
• Osteoarthritis
• Other Arthritis

Global Companion Animal Arthritis Market: By Application
• Dogs
• Cats
• Others

Global Companion Animal Arthritis Market: Regional Analysis
All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global Companion Animal Arthritis market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.
Report Attribute/MetricDetails
Market Size 2021$2.9 Billion 
Market Size 2031$5.5 Billion 
Compound Annual Growth Rate (CAGR)7%(2022-2031)
Base Year2022
Forecast Period2023-2032
Historical Data2018-2022
Forecast UnitsValue ($ Billion)
Report CoverageRevenue Forecast, Competitive Landscape,
Growth Factors, and Trends 
By Type• Osteoarthritis
• Other Arthritis

By Application• Dogs
• Cats
Key Companies Profiled• Zoetis
• Virbac
• Elanco
• Boehringer Ingelheim International GmbH
• Ceva
• Dechra Pharmaceuticals PLC.
• Vetoquinol
• NexGen Pharmaceuticals
• Norbrook
• Eltech K-Laser s.r.l.

Regions and Key Countries CoveredU.S., Canada, and Mexico in North America, Germany, France, U.K.,
Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium,
and Rest of Europe in Europe, Singapore, Malaysia, Australia,
Thailand, Indonesia, Philippines, China, Japan, India,
South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC),
Saudi Arabia, U.A.E, South Africa, Egypt, Israel,
Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA),
and Argentina, Brazil, and Rest of South America as part of South America
Customization ScopeAvailable on Request

Reasons to Purchase Companion Animal Arthritis Market Report:
• To gain insights into market trends and dynamics: this reports provide valuable insights into industry trends and dynamics, including market size, growth rates, and key drivers and challenges.
• To identify key players and competitors: this research reports can help businesses identify key players and competitors in their industry, including their market share, strategies, and strengths and weaknesses.
• To understand consumer behavior: this research reports can provide valuable insights into consumer behavior, including their preferences, purchasing habits, and demographics.
• To evaluate market opportunities: this research reports can help businesses evaluate market opportunities, including potential new products or services, new markets, and emerging trends.
• To make informed business decisions: this research reports provide businesses with data-driven insights that can help them make informed business decisions, including strategic planning, product development, and marketing and advertising strategies.
Overall, market research reports provide businesses and organizations with valuable information that can help them make informed decisions and stay competitive in their industry. They can provide a solid foundation for business planning, strategy development, and decision-making.

Objectives of Companion Animal Arthritis Market Study:
The objectives of Companion Animal Arthritis market research report may vary depending on the specific needs and goals of the business or organization commissioning the report. However, some common objectives of market research reports include:
Understanding the market size and potential: One of the primary objectives of Companion Animal Arthritis market research is to understand the size and potential of a particular market. This includes analyzing market trends and dynamics, identifying key players and competitors, and assessing the demand for products or services.
• Identifying target customers and segments: this market research reports can help businesses identify and understand their target customers and market segments, including their preferences, behaviors, and demographics. This information can be used to develop targeted marketing and advertising strategies.
• Evaluating product or service performance: this market research reports can provide valuable insights into the performance of products or services, including customer satisfaction, product usage, and product quality. This information can be used to improve products or services and enhance customer satisfaction.
• Assessing market opportunities and threats: this market research reports can help businesses identify potential market opportunities and threats, including emerging trends, competitive threats, and new market entrants. This information can be used to develop strategic plans and make informed business decisions.
• Developing effective marketing and advertising strategies: this market research reports can help businesses develop effective marketing and advertising strategies by providing insights into customer preferences and behavior, competitive dynamics, and market trends. This can help businesses improve brand awareness, customer engagement, and overall marketing effectiveness.
Overall, the objectives of Companion Animal Arthritis market research report are to provide businesses and organizations with valuable insights and data-driven recommendations that can help them make informed business decisions and stay competitive in their industry.

Frequently Asked Questions

  Companion Animal Arthritis Market size was valued at $2.9 Billion in 2021, and is projected to reach $5.5 Billion by 2031, growing at a CAGR of 7% from 2022 to 2031.

  The report would identify key drivers, such as the increasing prevalence of arthritis in companion animals, advancements in veterinary care, and the growing awareness among pet owners about arthritis management.

  Challenges might include the limited availability of specialized veterinary care, the cost of arthritis management, and the need for improved diagnostic tools.

  The report would list and profile major players in the market, including their product portfolios, market shares, and recent developments.

  The report might discuss trends such as early diagnosis, multimodal pain management, regenerative medicine, and telemedicine in veterinary care.

TABLE OF CONTENT

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Companion Animal Arthritis Market Size Growth Rate by Type: 2018 VS 2023 VS 2032
1.2.2 Osteoarthritis
1.2.3 Other Arthritis
1.3 Market by Application
1.3.1 Global Companion Animal Arthritis Market Growth by Application: 2018 VS 2023 VS 2032
1.3.2 Dogs
1.3.3 Cats
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Companion Animal Arthritis Market Perspective (2017-2032)
2.2 Companion Animal Arthritis Growth Trends by Region
2.2.1 Global Companion Animal Arthritis Market Size by Region: 2018 VS 2023 VS 2032
2.2.2 Companion Animal Arthritis Historic Market Size by Region (2017-2023)
2.2.3 Companion Animal Arthritis Forecasted Market Size by Region (2023-2032)
2.3 Companion Animal Arthritis Market Dynamics
2.3.1 Companion Animal Arthritis Industry Trends
2.3.2 Companion Animal Arthritis Market Drivers
2.3.3 Companion Animal Arthritis Market Challenges
2.3.4 Companion Animal Arthritis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Companion Animal Arthritis Players by Revenue
3.1.1 Global Top Companion Animal Arthritis Players by Revenue (2017-2023)
3.1.2 Global Companion Animal Arthritis Revenue Market Share by Players (2017-2023)
3.2 Global Companion Animal Arthritis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Companion Animal Arthritis Revenue
3.4 Global Companion Animal Arthritis Market Concentration Ratio
3.4.1 Global Companion Animal Arthritis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Companion Animal Arthritis Revenue in 2022
3.5 Companion Animal Arthritis Key Players Head office and Area Served
3.6 Key Players Companion Animal Arthritis Product Solution and Service
3.7 Date of Enter into Companion Animal Arthritis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Companion Animal Arthritis Breakdown Data by Type
4.1 Global Companion Animal Arthritis Historic Market Size by Type (2017-2023)
4.2 Global Companion Animal Arthritis Forecasted Market Size by Type (2023-2032)
5 Companion Animal Arthritis Breakdown Data by Application
5.1 Global Companion Animal Arthritis Historic Market Size by Application (2017-2023)
5.2 Global Companion Animal Arthritis Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America Companion Animal Arthritis Market Size (2017-2032)
6.2 North America Companion Animal Arthritis Market Growth Rate by Country: 2018 VS 2023 VS 2032
6.3 North America Companion Animal Arthritis Market Size by Country (2017-2023)
6.4 North America Companion Animal Arthritis Market Size by Country (2023-2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Companion Animal Arthritis Market Size (2017-2032)
7.2 Europe Companion Animal Arthritis Market Growth Rate by Country: 2018 VS 2023 VS 2032
7.3 Europe Companion Animal Arthritis Market Size by Country (2017-2023)
7.4 Europe Companion Animal Arthritis Market Size by Country (2023-2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Companion Animal Arthritis Market Size (2017-2032)
8.2 Asia-Pacific Companion Animal Arthritis Market Growth Rate by Region: 2018 VS 2023 VS 2032
8.3 Asia-Pacific Companion Animal Arthritis Market Size by Region (2017-2023)
8.4 Asia-Pacific Companion Animal Arthritis Market Size by Region (2023-2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Companion Animal Arthritis Market Size (2017-2032)
9.2 Latin America Companion Animal Arthritis Market Growth Rate by Country: 2018 VS 2023 VS 2032
9.3 Latin America Companion Animal Arthritis Market Size by Country (2017-2023)
9.4 Latin America Companion Animal Arthritis Market Size by Country (2023-2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Companion Animal Arthritis Market Size (2017-2032)
10.2 Middle East & Africa Companion Animal Arthritis Market Growth Rate by Country: 2018 VS 2023 VS 2032
10.3 Middle East & Africa Companion Animal Arthritis Market Size by Country (2017-2023)
10.4 Middle East & Africa Companion Animal Arthritis Market Size by Country (2023-2032)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Zoetis
11.1.1 Zoetis Company Detail
11.1.2 Zoetis Business Overview
11.1.3 Zoetis Companion Animal Arthritis Introduction
11.1.4 Zoetis Revenue in Companion Animal Arthritis Business (2017-2023)
11.1.5 Zoetis Recent Development
11.2 Virbac
11.2.1 Virbac Company Detail
11.2.2 Virbac Business Overview
11.2.3 Virbac Companion Animal Arthritis Introduction
11.2.4 Virbac Revenue in Companion Animal Arthritis Business (2017-2023)
11.2.5 Virbac Recent Development
11.3 Elanco
11.3.1 Elanco Company Detail
11.3.2 Elanco Business Overview
11.3.3 Elanco Companion Animal Arthritis Introduction
11.3.4 Elanco Revenue in Companion Animal Arthritis Business (2017-2023)
11.3.5 Elanco Recent Development
11.4 Boehringer Ingelheim International GmbH
11.4.1 Boehringer Ingelheim International GmbH Company Detail
11.4.2 Boehringer Ingelheim International GmbH Business Overview
11.4.3 Boehringer Ingelheim International GmbH Companion Animal Arthritis Introduction
11.4.4 Boehringer Ingelheim International GmbH Revenue in Companion Animal Arthritis Business (2017-2023)
11.4.5 Boehringer Ingelheim International GmbH Recent Development
11.5 Ceva
11.5.1 Ceva Company Detail
11.5.2 Ceva Business Overview
11.5.3 Ceva Companion Animal Arthritis Introduction
11.5.4 Ceva Revenue in Companion Animal Arthritis Business (2017-2023)
11.5.5 Ceva Recent Development
11.6 Dechra Pharmaceuticals PLC.
11.6.1 Dechra Pharmaceuticals PLC. Company Detail
11.6.2 Dechra Pharmaceuticals PLC. Business Overview
11.6.3 Dechra Pharmaceuticals PLC. Companion Animal Arthritis Introduction
11.6.4 Dechra Pharmaceuticals PLC. Revenue in Companion Animal Arthritis Business (2017-2023)
11.6.5 Dechra Pharmaceuticals PLC. Recent Development
11.7 Vetoquinol
11.7.1 Vetoquinol Company Detail
11.7.2 Vetoquinol Business Overview
11.7.3 Vetoquinol Companion Animal Arthritis Introduction
11.7.4 Vetoquinol Revenue in Companion Animal Arthritis Business (2017-2023)
11.7.5 Vetoquinol Recent Development
11.8 NexGen Pharmaceuticals
11.8.1 NexGen Pharmaceuticals Company Detail
11.8.2 NexGen Pharmaceuticals Business Overview
11.8.3 NexGen Pharmaceuticals Companion Animal Arthritis Introduction
11.8.4 NexGen Pharmaceuticals Revenue in Companion Animal Arthritis Business (2017-2023)
11.8.5 NexGen Pharmaceuticals Recent Development
11.9 Norbrook
11.9.1 Norbrook Company Detail
11.9.2 Norbrook Business Overview
11.9.3 Norbrook Companion Animal Arthritis Introduction
11.9.4 Norbrook Revenue in Companion Animal Arthritis Business (2017-2023)
11.9.5 Norbrook Recent Development
11.10 Eltech K-Laser s.r.l.
11.10.1 Eltech K-Laser s.r.l. Company Detail
11.10.2 Eltech K-Laser s.r.l. Business Overview
11.10.3 Eltech K-Laser s.r.l. Companion Animal Arthritis Introduction
11.10.4 Eltech K-Laser s.r.l. Revenue in Companion Animal Arthritis Business (2017-2023)
11.10.5 Eltech K-Laser s.r.l. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Zoetis
Virbac
Elanco
Boehringer Ingelheim International GmbH
Ceva
Dechra Pharmaceuticals PLC.
Vetoquinol
NexGen Pharmaceuticals
Norbrook
Eltech K-Laser s.r.l.

Request Sample